Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06606743 · ClinicalTrials.gov registry record · NA
Interval Training and Parkinson's Disease
A NA study of Other Disorders of Autonomic Nervous System, sponsored by University of Miami.
- Completed
- Registry status
- NA
- Development phase
- 39
- Enrollment target
- 2
- Study locations
NCT06606743: Completed NA study of Other Disorders of Autonomic Nervous System, sponsored by University of Miami.
NCT06606743 is a NA study of Other Disorders of Autonomic Nervous System that has completed, run by University of Miami. The registered enrollment target is 39 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06606743, a NA study of Other Disorders of Autonomic Nervous System, has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- NA
- Development phase
- 39 participants
- Enrollment target
- 2
- Study locations
Study Summary
This research is designed to compare the impact of high-intensity interval training and high-velocity circuit resistance training on heart rate variability, gait, and functional performance in patients with Parkinsons disease.
Primary Outcome
After a 10-minute supine rest on a padded treatment table, subjects will breathe at a rate of six breaths per minute for two minutes. The heart rate will be monitored using a Polar heart rate monitor and variations will be detected using the elite application via mobile device.
Conditions Studied
Interventions
- BEHAVIORAL High-Intensity Interval Training
- BEHAVIORAL High-Velocity Circuit Resistance Training
Study Locations (2)
Florida
- University of Miami - Coral Gables
- Laboratory of Neruomuscular Research and Active Aging - Coral Gables
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2024-09-20 |
| Est. Completion | 2025-06-30 |
| Phase | NA |
What the finished NCT06606743 record still lists
NCT06606743 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 39 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Other Disorders of Autonomic Nervous System appearing as the primary indexed condition, and to 2 interventions - of which High-Intensity Interval Training is the first listed.
NCT06606743 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT06606743 about?
NCT06606743 is a clinical study titled "Interval Training and Parkinson's Disease". This research is designed to compare the impact of high-intensity interval training and high-velocity circuit resistance training on heart rate variability, gait, and functional performance in patients with Parkinsons disease.
What is the current status of trial NCT06606743?
This trial is currently completed. It is a NA study. The enrollment target is 39 participants. The study started on 2024-09-20. Estimated completion is 2025-06-30.
What conditions does trial NCT06606743 study?
This clinical trial studies the following conditions: Other Disorders of Autonomic Nervous System.
What interventions are being tested in trial NCT06606743?
The interventions under investigation include: High-Intensity Interval Training (BEHAVIORAL), High-Velocity Circuit Resistance Training (BEHAVIORAL).
Who is sponsoring clinical trial NCT06606743?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06606743 being conducted?
This trial has 2 study locations across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06606743's enrollment target sits among peer trials
39 1536th of 2000 higher than 463 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03465592 · 39 participants · Phase 1
Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma
- NCT03961776 · 39 participants
Monitoring Treatment Response With On-board DWI During Neo-adjuvant Chemo-radiation for Rectal Cancer Using Magnetic Resonance-guided-radiotherapy Systems
- NCT04050280 · 39 participants · Phase 2
CLAG-GO for Patients With Persistent, Relapsed or Refractory AML
- NCT04190862 · 39 participants · Phase 1
E-CEL UVEC as an Adjunct Cell Therapy for Treatment of Anal Fistulas
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI